Annual Cash & Cash Equivalents
$2.96 M
-$17.49 M-85.53%
December 1, 2023
Summary
- As of February 7, 2025, ACTU annual cash & cash equivalents is $2.96 million, with the most recent change of -$17.49 million (-85.53%) on December 1, 2023.
- During the last 3 years, ACTU annual cash & cash equivalents has fallen by -$17.49 million (-85.53%).
- ACTU annual cash & cash equivalents is now -85.53% below its all-time high of $20.45 million, reached on December 1, 2022.
Performance
ACTU Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$13.52 M
+$13.17 M+3745.15%
September 1, 2024
Summary
- As of February 7, 2025, ACTU quarterly cash and cash equivalents is $13.52 million, with the most recent change of +$13.17 million (+3745.15%) on September 1, 2024.
- Over the past year, ACTU quarterly cash and cash equivalents has increased by +$13.17 million (+3745.15%).
- ACTU quarterly cash and cash equivalents is now at all-time high.
Performance
ACTU Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
ACTU Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -85.5% | +3745.2% |
| 3 y3 years | -85.5% | +3745.2% |
| 5 y5 years | -85.5% | +3745.2% |
ACTU Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -85.5% | at low | at high | +3745.2% |
| 5 y | 5-year | -85.5% | at low | at high | +3745.2% |
| alltime | all time | -85.5% | at low | at high | +3745.2% |
Actuate Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $13.52 M(+3745.2%) |
| Jun 2024 | - | $351.70 K(-83.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2024 | - | $2.07 M(-30.1%) |
| Dec 2023 | $2.96 M(-85.5%) | $2.96 M |
| Dec 2022 | $20.45 M | - |
FAQ
- What is Actuate Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Actuate Therapeutics?
- What is Actuate Therapeutics annual cash & cash equivalents year-on-year change?
- What is Actuate Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Actuate Therapeutics?
- What is Actuate Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Actuate Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of ACTU is $2.96 M
What is the all time high annual cash & cash equivalents for Actuate Therapeutics?
Actuate Therapeutics all-time high annual cash & cash equivalents is $20.45 M
What is Actuate Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, ACTU annual cash & cash equivalents has changed by -$17.49 M (-85.53%)
What is Actuate Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of ACTU is $13.52 M
What is the all time high quarterly cash and cash equivalents for Actuate Therapeutics?
Actuate Therapeutics all-time high quarterly cash and cash equivalents is $13.52 M
What is Actuate Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, ACTU quarterly cash and cash equivalents has changed by +$13.17 M (+3745.15%)